Information  X 
Enter a valid email address

Tissue Regenix Grp PLC Ord0.1P (TRX)

Related News

28-Apr-2021 09:29 AM

Tissue Regenix losses deepen on impairment charge; lower sales

Regenerative medical devices company Tissue Regenix posted a deeper annual loss as sales slipped and it wrote down the value of its CellRight Technologies business, acquired in 2017. Pre-tax losses for the year through December amounted to £10.2 mi
18-Mar-2021 08:52 AM

Tissue Regenix completes initial phase of US facility expansion plan

Tissue Regenix, the regenerative medical devices company, completed the initial phase of its expansion plan at its US-based San Antonio Texas facility by securing a ten-year lease on a 21,000 sq.ft facility adjacent to its existing one to address manufact
11-Feb-2021 09:03 AM

Tissue Regenix to switch to electronic shareholder communications

Regenerative medical devices company Tissue Regenix has outlined plans to switch to electronic communication methods for shareholder documents. The company stated that the move is part of its environmental sustainability efforts and to ensure timely and
08-Feb-2021 08:05 AM

Tissue Regenix expects annual revenue to slip 2%

Regenerative medical devices company Tissue Regenix said it expected its annual revenue to slip 2%, in what it described as a 'strong' performance against a challenging Covid-19 backdrop. Revenue or the year through December was expected to fal
21-Jan-2021 08:24 AM

Tissue Regenix appoints CFO

Medical devices company Tissue Regenix has appointed David Cocke as CFO and director to the board with immediate effect. Mr Cocke has over 29 years of experience in the medical device industry holding senior finance and operations positions. In 1997,
02-Sep-2020 07:47 AM

Tissue Regenix losses narrow on cost cutting

Regenerative medical devices company Tissue Regenix posted a narrower first-half loss after it cut overheads. Pre-tax losses for the six months through June amounted to £2.7m, compared to losses of £4.4m on-year. Revenue was broadly flat at
05-Jun-2020 09:03 AM

Tissue Regenix posts annual loss as expenses offset rising sales

Regenerative medical devices company Tissue Regenix posted a full-year loss, after rising sales were more than offset by expenses. Pre-tax losses for the year through December amounted to £7.7m, compared to losses of £8.9m on-year. Revenue r
22-Jan-2020 07:41 AM

Tissue Regenix revenue up 12%; still seeking alternative funding

Regenerative medical devices company Tissue Regenix said it would post annual revenue growth of 12% and was continuing to assess various funding options to alleviate significant working capital constraints. The company said its current cash position of &
10-Sep-2019 03:02 PM

Tissue Regenix posts first-half loss; sees better second half

Regenerative medical devices company Tissue Regenix posted a first-half loss but said it expected to post a better performance in the second half owing to growing demand for its products. Pre-tax losses for the six months through June amounted to £
01-Aug-2019 09:45 AM

CEO Steve Couldwell resigns from Tissue Regenix due to illness

Regenerative medical devices company Tissue Regenix Group said that CEO Steve Couldwell had resigned his position 'with immediate effect' due to a recurrence of illness. The firm said John Samuel would resume the position of executive chairman
04-Feb-2019 02:17 PM

Tissue Regenix moves closer to profitability as revenue jumps

Regenerative medical devices company Tissue Regenix Group said it expected to move closer to its goal of generating 'sustainable profitability' in 2019 after it more than doubled its annual revenue. Revenue for the year through December, 2018 w
03-Sep-2018 09:21 AM

Tissue Regenix posts loss as costs offset higher revenue

Regenerative medical devices company Tissue Regenix Group posted a first-half loss, as higher revenue was offset by costs. Pre-tax losses for the six months through June amounted to £4.3m, narrowing from £5.4m of losses on-year. Sales increa
02-Nov-2017 09:06 AM

Tissue Regenix appoints CEO

Tissue Regenix, a regenerative medical devices company, has appointed Steve Couldwell as chief executive officer of the group, effective immediately. Couldwell has been a non- executive director since July 2013. He has over 25 years' experience in
08-Aug-2017 01:51 PM

All resolutions passed at GM of Tissue Regenix

Tissue Regenix Group has confirmed that all resolutions, including those in respect of the Offer and Acquisition announced by the Company on 20 July, were passed by shareholders at today's General Meeting. Accordingly, the Company has applied to the
02-Jun-2017 07:28 AM

Tissue Regenix widens FY pretax loss, revenue up

Tissue Regenix has reported a year of significant progress as it lifted revenue, but saw its pre-tax loss for the period widen. "The growing momentum behind our portfolio of pioneering regenerative medical devices has increased with market adoption,
31-May-2017 03:01 PM

Tissue Regenix updates on potential acquisition of CellRight

Tissue Regenix Group said it has noted the recent dissolution of the temporary restraining order ("TRO") issued by Bexar County District Court against CellRight Technologies in relation to a potential sale of CellRight to Tissue Regenix. Tissue
19-May-2017 02:08 PM

Tissue Regenix looks to acquire CellRight

Tissue Regenix Group said it has noted the recent application for a temporary restraining order filed by one of the members of CellRight Technologies, with Bexar County District Court against CellRight, in relation to a potential sale of CellRight to Tiss
06-Jan-2017 07:10 AM

Tissue Regenix appoints Paul Devlin as group FD

Tissue Regenix Group announces the appointment of Paul Devlin as Group Finance Director and Company Secretary with immediate effect. Story provided by StockMarketWire.com...
12-Oct-2016 07:45 AM

Tissue Regenix widens H1 pretax loss

Tissue Regenix has widened its H1 pretax loss to £5.4m, from a year-earlier loss of £4.0m. Revenue was just £631,000, from £252,000. Most of the losses were administrative expenses. "The next twelve months promise some signif
15-Sep-2016 03:19 PM

Edison research outlook on Tissue Regenix

Edison has issued research outlook on Tissue Regenix. It says: "Tissue Regenix's (TRX) investment story is built on dCELL, a versatile regenerative medical technology and its potential applications across the subsectors: cardiac, wound care and
04-Jul-2016 03:29 PM

Tissue Regenix resolutions passed at AGM

Tissue Regenix Group has confirmed that all resolutions proposed at its annual general meeting today were passed. At 3:29pm: (LON:TRX) Tissue Regenix Group PLC share price was 0p at 18p Story provided by StockMarketWire.com...
01-Jul-2016 08:39 AM

Tissue Regenix Wound Care secures contract agreement with GPO

Tissue Regenix (TRX) announced that Tissue Regenix Wound Care secured a contract agreement with a national US group purchasing organisation (GPO) for the use of DermaPure. A GPO negotiates contracts and pricing with an integrated delivery network (IDN) o
23-May-2016 07:38 AM

Tissue Regenix widens FY pretax loss

Tissue Regenix has widened its FY pretax loss to GBP10.0m, from a year-ago loss of GBP8.2m. Revenue was GBP0.8m, from GB0.1m, with administrative expenses responsible for most of the losses. "During the year to 31 January 2016 Tissue Regenix made si
14-Mar-2016 08:40 AM

Broker Forecast - Jefferies International issues a broker note on Tissue Regenix Group PLC

Jefferies International today reaffirms its buy investment rating on Tissue Regenix Group PLC (LON:TRX) and raised its price target to 37p (from 36p). Story provided by StockMarketWire.com...
26-Jan-2016 12:31 PM

Tissue Regenix enters into JVA with GTM-V

Tissue Regenix Group has announced first step towards the commercialisation of human dCELL heart valves and DermaPure in the EU through a Joint Venture Agreement with a German tissue bank. Highlights - Joint Venture Agreement ("JVA") entered i

a d v e r t i s e m e n t